Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

J M Olivares

Biographic Data

ID7639915
NAMEJ M Olivares
GIVEN NAMESJ M
FAMILY NAMEOlivares
SIGNATUREOLIVARES J M
AFFILIATIONSUniversity Hospital Complex Of Vigo
ORCID0000-0003-2480-4356
VERIFIEDYes
TOTAL WORKS5
TOTAL CITATIONS0
WORKS AS AUTHOR5
WORKS AS EDITOR0
FIRST PUBLICATION YEAR1995
LATEST PUBLICATION YEAR2024
H-INDEX0
  • Neurofilament light chain plasma levels in major depressive disorder

    Open Access•Carlos Fernández-Pereira, María de los Ángeles Fernández-Ceballos et al.•ARTICLE•Frontiers in Psychiatry•2024

    Significant alteration in NfL plasma levels in MDD patients might reflect neurobiological changes behind the predisposition to develop future neurodegenerative disorders such as Alzheimer's or Parkinson's diseases for which depression represents a risk factor. However, whether there is an increase in NfL due to MDD regardless of the ageing process is still a matter of debate

  • Long-Term Real-World Effectiveness of Aripiprazole Once-Monthly. Treatment Persistence and Its Correlates in the Italian and Spanish Clinical Practice

    Open Access•J M Olivares, Andrea Fagiolini•ARTICLE•Frontiers in Psychiatry•2022

    The AOM persistence rate observed in this study was 82.4%, which was higher than that reported in clinical trials, aligned with other real-life studies and higher than reported for other long-acting injectable antipsychotics. The persistence rate was high in complex patients, although patients with higher level of education, active occupation, lower initial CGI-S score and shorter time since the diagnosis of schizophrenia appear to be more likely…

  • Efficacy of the Therapeutic Game “Trisquel” in the Treatment of Patients With Substance-Related Disorders Randomized Clinical Study

    Open Access•Adolfo Piñón Blanco, Adolfo Piñón-Blanco et al.•ARTICLE•Frontiers in Psychiatry•2022

    Substance-related disorders (SRD) have been consistently associated with alterations both in cognitive and executive functions, which affect to patients' quality of life. The main objective of this work was to test the beneficial cognitive effects on patients with SRD after the implementation of "Trisquel," an intervention program in board game format. To check the effectiveness of Trisquel program, a group of people diagnosed with SRD was random…

  • Proteomics in Schizophrenia

    Open Access•Daniela Rodrigues-Amorim, Tania Rivera‐Baltanás et al.•ARTICLE•Frontiers in Psychiatry•2019

    Schizophrenia is a severe and disabling psychiatric disorder with a complex and multifactorial etiology. The lack of consensus regarding the multifaceted dysfunction of this ailment has increased the need to explore new research lines. This research makes use of proteomics data to discover possible analytes associated with psychoneuroimmune signaling pathways in schizophrenia. Thus, we analyze plasma of 45 patients [10 patients with first-episode…

  • The anhedonias

    Open Access•G E Berrios, J M Olivares•ARTICLE•History of Psychiatry•1995

    Background. The term and concept of 'anhedonia' refer to a group of clinical phenomena whose common denominator is the complaint of a putative incapacity to 'experience pleasure'. Linked to disorders such as schizophrenia and depression, anhedonia remains difficult to define and measure. Method. This paper explores the historical frames in which anhedonia was originally constructed; and is fully based on primary sources. It makes use of the 'conc…

No prominent works on this page.

  • The anhedonias

    Open Access•G E Berrios, J M Olivares•ARTICLE•History of Psychiatry•1995

    Background. The term and concept of 'anhedonia' refer to a group of clinical phenomena whose common denominator is the complaint of a putative incapacity to 'experience pleasure'. Linked to disorders such as schizophrenia and depression, anhedonia remains difficult to define and measure. Method. This paper explores the historical frames in which anhedonia was originally constructed; and is fully based on primary sources. It makes use of the 'conc…

  • Proteomics in Schizophrenia

    Open Access•Daniela Rodrigues-Amorim, Tania Rivera‐Baltanás et al.•ARTICLE•Frontiers in Psychiatry•2019

    Schizophrenia is a severe and disabling psychiatric disorder with a complex and multifactorial etiology. The lack of consensus regarding the multifaceted dysfunction of this ailment has increased the need to explore new research lines. This research makes use of proteomics data to discover possible analytes associated with psychoneuroimmune signaling pathways in schizophrenia. Thus, we analyze plasma of 45 patients [10 patients with first-episode…

  • Long-Term Real-World Effectiveness of Aripiprazole Once-Monthly. Treatment Persistence and Its Correlates in the Italian and Spanish Clinical Practice

    Open Access•J M Olivares, Andrea Fagiolini•ARTICLE•Frontiers in Psychiatry•2022

    The AOM persistence rate observed in this study was 82.4%, which was higher than that reported in clinical trials, aligned with other real-life studies and higher than reported for other long-acting injectable antipsychotics. The persistence rate was high in complex patients, although patients with higher level of education, active occupation, lower initial CGI-S score and shorter time since the diagnosis of schizophrenia appear to be more likely…

  • Efficacy of the Therapeutic Game “Trisquel” in the Treatment of Patients With Substance-Related Disorders Randomized Clinical Study

    Open Access•Adolfo Piñón Blanco, Adolfo Piñón-Blanco et al.•ARTICLE•Frontiers in Psychiatry•2022

    Substance-related disorders (SRD) have been consistently associated with alterations both in cognitive and executive functions, which affect to patients' quality of life. The main objective of this work was to test the beneficial cognitive effects on patients with SRD after the implementation of "Trisquel," an intervention program in board game format. To check the effectiveness of Trisquel program, a group of people diagnosed with SRD was random…

  • Neurofilament light chain plasma levels in major depressive disorder

    Open Access•Carlos Fernández-Pereira, María de los Ángeles Fernández-Ceballos et al.•ARTICLE•Frontiers in Psychiatry•2024

    Significant alteration in NfL plasma levels in MDD patients might reflect neurobiological changes behind the predisposition to develop future neurodegenerative disorders such as Alzheimer's or Parkinson's diseases for which depression represents a risk factor. However, whether there is an increase in NfL due to MDD regardless of the ageing process is still a matter of debate

Psychology (5 works) · Medicine (4 works) · Psychiatry (4 works) · Anhedonia (2 works) · Clinical Psychology (2 works) · Internal Medicine (2 works) · Psychotherapist (2 works) · Schizophrenia (object-oriented programming (2 works) · Schizophrenia research and treatment (2 works) · Tryptophan and brain disorders (2 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae